• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早发型和晚发型阿尔茨海默病痴呆患者脑脊液中的单胺代谢产物及行为评分

Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.

作者信息

Bråne G, Gottfries C G, Blennow K, Karlsson I, Lekman A, Parnetti L, Svennerholm L, Wallin A

机构信息

Department of Psychiatry and Neurochemistry, St. Jörgen's Hospital, Gothenburg University, Sweden.

出版信息

Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004.

DOI:10.1097/00002093-198903030-00004
PMID:2477044
Abstract

Patients with Alzheimer disease (AD, onset less than 65 years of age, n = 13) and senile dementia of the Alzheimer type (SDAT, onset greater than or equal to 65 years of age, n = 28) were investigated for cerebrospinal fluid (CSF) content of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA) and 3-methoxy-4-hydroxy-phenylglycol (MHPG) and compared with a group of controls (n = 26). A geriatric rating scale, the Gottfries-Bråne-Steen scale, was used to assess impairment of motor performance, intellectual and emotional functioning, and symptoms common in dementia disorders. The HVA levels in CSF were significantly lower in the AD group than in the SDAT group and controls. MHPG was slightly but significantly increased in the SDAT group when compared with the controls. The HVA and 5-HIAA concentrations were correlated negatively with impairment of motor performance in the SDAT group; 5-HIAA correlated positively with impaired performance in the AD group; and 5-HIAA/HVA ratios were correlated positively with the performance variables. HVA correlated significantly and negatively with "impaired wakefulness" and "inability to increase tempo" in the SDAT group. 5-HIAA and the ratio 5-HIAA/HVA correlated significantly and positively with some items measuring intellectual and emotional impairment. In the AD group, "anxiety" and "fear-panic" correlated positively with 5-HIAA and "restlessness" with MHPG. The data indicate qualitative differences in the CSF monoamine pattern between AD and SDAT.

摘要

对阿尔茨海默病(AD,发病年龄小于65岁,n = 13)和阿尔茨海默型老年痴呆症(SDAT,发病年龄大于或等于65岁,n = 28)患者的脑脊液(CSF)中高香草酸(HVA)、5-羟吲哚乙酸(5-HIAA)和3-甲氧基-4-羟基苯乙二醇(MHPG)含量进行了研究,并与一组对照者(n = 26)进行比较。使用一种老年评定量表——戈特弗里斯-布劳内-斯滕量表,来评估运动表现、智力和情感功能的损害以及痴呆症常见症状。AD组脑脊液中的HVA水平显著低于SDAT组和对照组。与对照组相比,SDAT组的MHPG略有但显著升高。在SDAT组中,HVA和5-HIAA浓度与运动表现损害呈负相关;在AD组中,5-HIAA与表现受损呈正相关;5-HIAA/HVA比值与表现变量呈正相关。在SDAT组中,HVA与“觉醒受损”和“无法加快节奏”显著负相关。5-HIAA和5-HIAA/HVA比值与一些测量智力和情感损害的项目显著正相关。在AD组中,“焦虑”和“恐惧-惊恐”与5-HIAA呈正相关,“坐立不安”与MHPG呈正相关。数据表明AD和SDAT之间脑脊液单胺模式存在质的差异。

相似文献

1
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.早发型和晚发型阿尔茨海默病痴呆患者脑脊液中的单胺代谢产物及行为评分
Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004.
2
CSF monoamine metabolites in old age dementias.
Mol Chem Neuropathol. 1992 Feb-Apr;16(1-2):143-57. doi: 10.1007/BF03159966.
3
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.经组织学证实的阿尔茨海默病痴呆患者腰椎脑脊液中的单胺代谢物浓度。
J Neurol Neurosurg Psychiatry. 1984 May;47(5):481-4. doi: 10.1136/jnnp.47.5.481.
4
CSF monoamine metabolites in schizophrenic patients.精神分裂症患者脑脊液中的单胺代谢产物。
Acta Psychiatr Scand. 1982 Nov;66(5):350-60. doi: 10.1111/j.1600-0447.1982.tb06717.x.
5
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.阿尔茨海默病患者脑脊液中加压素水平:与单胺代谢产物及神经心理学测试表现的相关性
Psychoneuroendocrinology. 1989;14(1-2):89-95. doi: 10.1016/0306-4530(89)90057-7.
6
Neuropsychological test performance and CSF levels of monoamine metabolites in healthy volunteers and patients with Alzheimer's dementia.健康志愿者和阿尔茨海默病痴呆患者的神经心理学测试表现及脑脊液中单胺代谢物水平
Acta Psychiatr Scand. 1987 Dec;76(6):648-56. doi: 10.1111/j.1600-0447.1987.tb02935.x.
7
Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.阿尔茨海默病中脑脊液高香草酸(HVA)和5-羟吲哚乙酸(5-HIAA)水平降低的意义。
Neurobiol Aging. 1992 Jan-Feb;13(1):107-13. doi: 10.1016/0197-4580(92)90017-r.
8
CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.阿尔茨海默病和重度抑郁症中的脑脊液单胺代谢产物与生长抑素
Biol Psychiatry. 1991 Jun 1;29(11):1110-8. doi: 10.1016/0006-3223(91)90253-i.
9
CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.阿尔茨海默病和帕金森病患者脑脊液中单胺代谢物水平
Arch Neurol. 1985 May;42(5):489-92. doi: 10.1001/archneur.1985.04060050091016.
10
Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry.
Acta Psychiatr Scand. 1987 May;75(5):542-8. doi: 10.1111/j.1600-0447.1987.tb02831.x.

引用本文的文献

1
Dopamine System Dysfunction in Alzheimer's Disease.阿尔茨海默病中的多巴胺系统功能障碍
Psychogeriatrics. 2025 Sep;25(5):e70097. doi: 10.1111/psyg.70097.
2
Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms.阿尔茨海默病病理学:中枢去甲肾上腺素活性、记忆与神经精神症状之间的通路
Mol Psychiatry. 2021 Mar;26(3):897-906. doi: 10.1038/s41380-019-0437-x. Epub 2019 May 28.
3
Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease.
SSRIs 治疗阿尔茨海默病的潜在认知增强和疾病修饰作用。
Neuropsychiatr Dis Treat. 2007;3(5):627-36.
4
The biological basis of behavioral symptoms in dementia.痴呆行为症状的生物学基础。
Issues Ment Health Nurs. 2000 Jan-Feb;21(1):91-107. doi: 10.1080/016128400248284.
5
Noradrenergic hyperactivity after partial fornix section: role in cholinergic dependent memory performance.穹窿部分切断术后去甲肾上腺素能功能亢进:在胆碱能依赖性记忆表现中的作用。
Exp Brain Res. 1992;89(1):125-32. doi: 10.1007/BF00229009.